Evidence is information that demonstrates that a hypothesis is true - it's a test that provides confidence the result was caused by the intervention and that...
Clinical Cancer Research 15, 2523, April 1, 2009. Published Online First March 10, 2009; doi: 10.1158/1078-0432.CCR-08-1403 Identification of CD20 C-Terminal...
Clinical Cancer Research 15, 2488, April 1, 2009. Published Online First March 24, 2009; doi: 10.1158/1078-0432.CCR-08-1930 Clinical and Biological Effects of...
Blood First Edition Paper, prepublished online March 31, 2009; DOI 10.1182/blood-2008-10-185686. Aberrant regulation of pVHL levels by microRNA promotes the...
This targeted drug is being investigated also as lymphomas and CLL therapy: See studies: http://tinyurl.com/dftxrd Approval for one indication generally making...
Greetings, Patient reported symptoms (PRS) are an important part of managing lymphomas, but our reports are admittedly subjective - can be magnifide or...
Blood, 2 April 2009, Vol. 113, No. 14, pp. 3276-3286. Prepublished online as a Blood First Edition Paper on February 5, 2009; DOI 10.1182/blood-2008-08-173369....
I will be out of the office starting 04/03/2009 and will not return until 04/13/2009. I will respond to your message when I return. I will have limited/no...
Kenneth Savell
ksavell@...
Apr 4, 2009 2:25 am
12118
On "open-mindedness" http://scienceblogs.com/insolence/2009/04/on_open-mindedness.php...
re: "coverage for at least one PET scan, as prescribed by their physicians." Reflecting that some uses of PET have been validated for lymphoma .... but ...
Greetings, To say the system is complicated is an understatement! Immunity is among the least understood systems of the human body (Furman, MD). Recent...
Greetings, You are invited to participate in an interactive online video education program titled My Personal Lymphoma Journey sponsored by The Leukemia ...
re: not using rituxin if you had or ever had a health issue hepatitis? Yes, new guidance from NCCN is that prior to Rituxan, everyone should be first tested...
Everything ok in CLL Research land? I haven't received a list from you since March 29th. Hope all is well. Mary Versteeg ...
Mary Versteeg
mversteeg1@...
Apr 8, 2009 3:09 pm
12124
Published online first on April 7, 2009 [Clinical Cancer Research, 10.1158/1078-0432.CCR-08-2382] p65 Activity and ZAP-70 Status Predict the Sensitivity of...
Published online first on April 7, 2009 [Clinical Cancer Research, 10.1158/1078-0432.CCR-08-1694] CD20-Directed Small Modular Immunopharmaceutical, TRU-015,...
Cancer Epidemiology Biomarkers & Prevention 18, 1259, April 1, 2009. Published Online First March 31, 2009; doi: 10.1158/1055-9965.EPI-08-1037 Risk of...
See for what I hope to be a helpful list: http://www.lymphomation.org/cancer-centers.htm Added today centers that participate in NCCN guidelines. ~ Karl...
New Science/AAAS Webinar: Advances in Cancer Genomics April 30, 2009, 12 noon Eastern (9 a.m. Pacific, 4 p.m. GMT) Cancer is a complex family of diseases,...
Blood, 9 April 2009, Vol. 113, No. 15, pp. 3397-3405. Prepublished online as a Blood First Edition Paper on October 16, 2008; DOI 10.1182/blood-2008-07-168773....
Karl, I apologize for taking so long to comment, but life kept getting in the way. I'm presently being treated for a vitamin D deficiency. In addition to...
Greetings, See for Vorinostat lymphoma/cll studies: http://tinyurl.com/deasv5 (this targeted agent is already approved for cutaneous T-cell lymphoma) About...
Some drug, devicemakers worry comparative effectiveness research will limit patients' options. The Wall Street Journal (4/14, Zhang) reports, "Federal...
Greetings, Btk seems a highly plausible and selective target for b-cell lymphomas. Copying some background and clinical trial information. ~ Karl === ...
p65 Activity and ZAP-70 Status Predict the Sensitivity of Chronic Lymphocytic Leukemia Cells to the Selective I{kappa}B Kinase Inhibitor BMS-345541. Monica...
CpG island methylation patterns in chronic lymphocytic leukemia. B Seeliger, S Wilop, R Osieka, O Galm, and E Jost Leuk Lymphoma, March 1, 2009; 50(3): 419-26....
Incorporating the use of GM-CSF in the treatment of chronic lymphocytic leukemia. A Ferrajoli Leuk Lymphoma, March 1, 2009; 50(3): 514-6. UT MD Anderson Cancer...
Overexpression of the Fas-inhibitory molecule TOSO: a novel antiapoptotic factor in chronic lymphocytic leukemia. CP Pallasch and CM Wendtner Leuk Lymphoma,...
[Immunoglobulin variable heavy chain region genetic constitution and mutation status in Chinese patients with chronic lymphocytic leukemia.] Y Zhang, L Chen, W...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
